Literature DB >> 833813

Synthesis and identification of the major metabolites of prazosin formed in dog and rat.

T H Althuis, H J Hess.   

Abstract

The 6-O-demethyl and 7-O-demethyl analogues of the new antihypertensive drug prazosin [2-[4-(2-furoyl)-piperazin-1-yl]-4-amino-6,7-dimethoxyquinazoline hydrochloride] have been unequivocally synthesized via separate ten-step reaction sequences starting from isovanillin and vanillin, respectively. The 6-O-demethyl derivative was found to be identical with the major prazosin metabolite formed in dog and rat, while the 7-O-demethyl derivative was identical with another, less prevalent but significant metabolite. Two minor metabolites of prazosin, 2-(1-piperazinyl)-4-amino-6,7-dimethoxyquinazoline and 2,4-diamino-6,7-dimethoxyquinazoline, are also described. All four metabolites are less potent blood pressure lowering agents in dogs than prazosin but may contribute to its antihypertensive effect, since they account for a major portion of the administered dose.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 833813     DOI: 10.1021/jm00211a031

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Comparative bioavailability study of two brands of prazosin-containing tablets in healthy volunteers.

Authors:  P J Guelen; T J Janssen; M H Lam; T B Vree; P S Exler
Journal:  Pharm Weekbl Sci       Date:  1990-10-19

2.  Design and Synthesis of Tesirine, a Clinical Antibody-Drug Conjugate Pyrrolobenzodiazepine Dimer Payload.

Authors:  Arnaud C Tiberghien; Jean-Noel Levy; Luke A Masterson; Neki V Patel; Lauren R Adams; Simon Corbett; David G Williams; John A Hartley; Philip W Howard
Journal:  ACS Med Chem Lett       Date:  2016-05-24       Impact factor: 4.345

3.  Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.

Authors:  P C Rubin; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

Review 4.  Metabolites of antihypertensive drugs. An updated review of their clinical pharmacokinetic and therapeutic implications.

Authors:  A Ebihara; A Fujimura
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

5.  Identification of a prazosin metabolite and some preliminary data on its kinetics in hypertensive patients.

Authors:  V K Piotrovskii; N N Veiko; O S Ryabokon; S F Postolnikov; V I Metelitsa
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of prazosin--1985.

Authors:  J Vincent; P A Meredith; J L Reid; H L Elliott; P C Rubin
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

7.  Photoaffinity label for the alpha 1-adrenergic receptor: synthesis and effects on membrane and affinity-purified receptors.

Authors:  H J Hess; R M Graham; C J Homcy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

Review 8.  Clinical pharmacokinetics of prazosin.

Authors:  P Jaillon
Journal:  Clin Pharmacokinet       Date:  1980 Jul-Aug       Impact factor: 6.447

9.  An alternative synthesis of Vandetanib (Caprelsa™) via a microwave accelerated Dimroth rearrangement.

Authors:  Kayleigh L Brocklesby; Jennifer S Waby; Chris Cawthorne; Graham Smith
Journal:  Tetrahedron Lett       Date:  2017-04-12       Impact factor: 2.415

10.  Investigating the spectrum of biological activity of ring-substituted salicylanilides and carbamoylphenylcarbamates.

Authors:  Jan Otevrel; Zuzana Mandelova; Matus Pesko; Jiahui Guo; Katarina Kralova; Frantisek Sersen; Marcela Vejsova; Danuta S Kalinowski; Zaklina Kovacevic; Aidan Coffey; Jozef Csollei; Des R Richardson; Josef Jampilek
Journal:  Molecules       Date:  2010-11-10       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.